Physician profile
David L Rajkowski
NPI 1386622140
$2,649.34
in general payments reported to CMS, 2019-2025
12 companies · $330 in 2025
The $330 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $454 · 2020: $214 · 2021: $72.42 · 2022: $279 · 2023: $380 · 2024: $920 · 2025: $330.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,610 · Entertainment: $20.69.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,609.79 |
| Entertainment | $20.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $852.32 | 2021-2025 | Dailies Total1, Precision 1, Total30 |
| Coopervision INC. | $570.90 | 2019-2025 | Myday Contact Lens, Misight Contact Lens |
| Maculogix, INC. | $352.26 | 2019-2020 | |
| Lkc Technologies, INC. | $253.84 | 2023-2025 | |
| Lumenis Be INC | $152.32 | 2022 | |
| Sun Pharmaceutical Industries INC. | $136.92 | 2020-2025 | |
| Topcon Healthcare, INC. | $106.66 | 2024 | |
| Abb Con-Cise Optical Group LLC | $77.29 | 2023 | Spectacle Lenses, Contact Lens |
| Optos, INC. | $62.15 | 2019-2023 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Sight Sciences, INC. | $51.36 | 2023 | Tearcare System |
| Tarsus Pharmaceuticals, INC. | $17.08 | 2024 | Xdemvy |
| Abbvie INC. | $16.24 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Rajkowski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.